Viral Antigens Market Players Eye Opportunities in Acquisition of Smaller Companies
- Progressions in informatics platforms and image analysis software for viral antigen detection
- Increased suitability of these devices to be utilized for several parallel applications in the research of viral antigens
- Increased adoption of viral antigens in the vaccine development.
According to the study, majority of the recently developed methods such as Electron Microscopy workflow are encouraging for progression in viral research. For instance, with expansion in image systems, it is probable to get image in real time and manufacture immunoassay results which are reproducible and efficient. Numerous outbreaks of transmittable ailments caused by viruses, such as AIDS, hepatitis, influenza, and the ongoing COVID-19, are generating urgency in the vaccine r&d. The outcome is projected to prompt rapid expansion of the viral antigens market.
Furthermore, new launches and increase in the product development, incorporating the launch of various new recombinant antigens for the expansion of antibody tests for COVID-19 is likely to further fast-track the growth of the viral antigens market.
How Huge is the ELISA Opportunity?
As per Fact.MR, ELISAs are extensively utilized as an efficient tool in the diagnosis and detection of virus infection. These immunoassays are gaining momentum as secure, specific, and fast, due to the capability to manufacture recombinant viral proteins. Implementation of ELISA for distinguishing viral antigens is likely to hold majority of the stakeholders’ share and grow at a substantial 8.2% CAGR amid the assessment period.
On the other hand, electron microscopy is swiftly emerging as a powerful method to recognise viral antigens and define their localization and structural organization in vaccines and viruses. With growing awareness of electron microscopy amid professionals in research of vaccine, market players are directing their focus to this segment. Implementation of electron microscopy is anticipated at a robust CAGR of 9.4% by 2025.
What Percentage of Revenues are Concentrated in US?
North America led by the US, is poised to account for around 48% of the overall market valuation amid the assessment period. Majority of players are focusing on increasing productivity, flexibility and redefine control productivity and throughput capabilities. Favourable government policies for vaccine development as well as notable progressions in biomedical research infrastructure are contributing to the region’s growth.
As per the study, Europe is likely to account for second biggest share in the global viral antigens market, ascribing to heightened funding for clinical research in all life science fields. With bigger accessibility of workforce and resources, key players are eyeing prospects in East Asia which is projected to reflect a notable growth prospects in the approaching years.
The study reveals that the key players are focusing on adopting partnership and collaboration strategies to fulfil demands of end users by offering technologically advanced products, and these strategies notably supporting the growth of the market.
The viral antigens market is projected to expand at a CAGR of 9% through 2030.
The insights presented here are from a research study on Viral Antigens Market by Fact.MR.
Explore Fact.MR's Comprehensive Coverage on Healthcare Landscape
Antibodies Market – The global antibodies market is projected to exceed an estimation of US$ 3,000 Million by 2022 end. In a new report by Fact.MR, regulatory and key scientific factors are discussed, and their influence from a commercial sense has been analyzed.
Bacterial Antigens Market – Fact.MR analyses that increasing incidences of infectious diseases and cancer and growing diagnosis of several ailments continues to drive the revenue expansion in global bacterial antigens market.
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
MARKET ACCESS DMCC Initiative